Je‐Jung Lee - Publications, H-index & Citations

Je‐Jung Lee

chonnam national university

42H指数

583论文数

9.5K被引数

收录论文 117

发表时间

Real-world effectiveness of bortezomib maintenance following VMP induction in transplant-ineligible multiple myeloma: a target trial emulation study 移植不适格多发性骨髓瘤患者中硼替佐米维持治疗在VMP诱导后的真实世界有效性：一项目标试验模拟研究

Annals of Hematology

IF2.4

2026-03-23

OAAI

Jung Yeon Lee; Suein Choi; Seungpil Jung; Sung-Soo Park; Jin Seok Kim; Seung-Hwan Shin; Young-Woo Jeon; Seung-Ah Yahng; Je-Jung Lee; Hyo Jung Kim; Gyeong-Won Lee; Hyeon-Seok Eom; Min Kyoung Kim; Yundeok Kim; Jihyun Kwon; Chang-Ki Min

Novel Wearable-Based Real-Time Temperature Monitoring in Hospitals for Febrile Adverse Events in Patients with Cancer: A Prospective Feasibility Study 基于可穿戴设备的医院实时体温监测在癌症患者发热性不良反应中的应用：一项前瞻性可行性研究

Sensors 2025, Vol. 25, Page 7111

IF3.5

2025-11-21

OAAI

Yun Kwan Kim; Seo-Yeon Ahn; Sun Jung Lee; Chae-Bin Song; YeWon Hong; Ray Kim; Hee Jo Baek; Hoon Kook; Mihee Kim; Ga-Young Song; Ho Cheol Jang; Sung-Hoon Jung; Deok-Hwan Yang; Je-Jung Lee; Hyeoung-Joon Kim; Gyung Chul Kim; Hoo Hyun Kim; Young-Shin Lee; Jae-Sook Ahn

A multicentre prospective phase II study of rituximab combined with bortezomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance (R-VRD) in patients with Waldenström's macroglobulinaemia (KMM1803)一项多中心前瞻性II期研究，评估利妥昔单抗联合硼替佐米、来那度胺和地塞米松，随后给予来那度胺维持治疗（R-VRD）在瓦尔登斯特罗姆巨球蛋白血症患者中的疗效（KMM1803）。

BRITISH JOURNAL OF HAEMATOLOGY

IF3.8

2025-11-01

PREAI

Jung, Sung-Hoon; Kim, Dajung; Lee, Je-Jung; Kim, Kihyun; Min, Chang-Ki; Lee, Jae Hoon; Lee, Won Sik; Lee, Ji Hyun; Lee, Gyeong Won; Kim, Min Kyoung; Shin, Ho-Jin; Kim, Hyo Jung; Yi, Jun Ho; Lee, Ho Sup

Challenges and limitations of chimeric antigen receptor T-cell therapies in solid tumors: why are approvals restricted to hematologic malignancies?嵌合抗原受体T细胞疗法在实体瘤中的挑战与局限性：为何其获批仅限于血液系统恶性肿瘤？

Journal of Hematology & Oncology

IF40.4

2025-10-29

OAAI

Manh-Cuong Vo; Van-Dinh-Huan Tran; Van-Tan Nguyen; Nodirjon Ruzimurodov; Dung Tran Trung; Sang Ki Kim; Sung-Hoon Jung; Je-Jung Lee

Apomorphine is a novel necroptosis inhibitor targeting mixed lineage kinase domain-like protein oligomerization 阿扑吗啡是一种新型的程序性坏死抑制剂，靶向混合谱系激酶结构域样蛋白寡聚化

Cell Death Discovery

IF7

2025-10-13

OAAI

Myeonggil Han; Dong-Hyun Seo; Man Sup Kwak; In Ho Park; Woo Joong Rhee; Hee Sue Kim; Eunkyeong Jeon; Je-Jung Lee; Cheol Ho Park; Nam Doo Kim; Taebo Sim; You-Sun Kim; Kyoung-Seok Ryu; Jeon-Soo Shin

Randomized Phase 3 study of pomalidomide cyclophosphamide dexamethasone versus pomalidomide dexamethasone in relapse or refractory myeloma: an Asian Myeloma Network study (AMN003)随机化III期研究：比较泊马利度胺联合环磷酰胺、地塞米松与泊马利度胺联合地塞米松治疗复发或难治性骨髓瘤的疗效——一项亚洲骨髓瘤网络研究（AMN003）

Blood Cancer Journal

IF11.6

2025-10-06

OAAI

Jin Seok Kim; Yang Song; Wei-Ying Jen; C. S. Chim; Je-Jung Lee; Sung-Soo Yoon; Soo Chin Ng; Gin Gin Gan; Hiroshi Handa; Jae Hoon Lee; Kihyun Kim; Shigeki Ito; Jeffrey Shang-Yi Huang; Chang Ki Min; Melissa Ooi Gaik Ming; Sanjay de Mel; Cinnie Soekojo; Xinhua Li; Neha Awasthi; Yogesh Pokharkar; Brian GM Durie; Wee-Joo Chng

Expanded and activated marrow-infiltrating lymphocytes exhibit potent antimyeloma activity against autologous multiple myeloma cells 扩增并活化的骨髓浸润淋巴细胞对自体多发性骨髓瘤细胞表现出强大的抗骨髓瘤活性。

Translational Oncology

IF4.1

2025-07-24

PREAI

Seo-Yeon Ahn; Manh-Cuong Vo; Van-Tan Nguyen; Van-Dinh-Huan Tran; Tien Nguyen Duc; Mihee Kim; Ga-Young Song; Jae-Sook Ahn; Deok-Hwan Yang; Hyeoung-Joon Kim; Sung-Hoon Jung; Je-Jung Lee

Real-world outcomes of maintenance therapy post-autologous stem cell transplantation in newly diagnosed multiple myeloma

BMC CANCER

IF3.4

2025-02-05

OAAI

Kang, Ka-Won; Kim, Dae Sik; Lee, Se Ryeon; Heo, Mi Hwa; Eom, Hyeon-Seok; Jung, Jongheon; Lee, Ji Hyun; Kim, Sung-Hyun; Koh, Youngil; Min, Chang-Ki; Lee, Seung Shin; Lim, Sung-Nam; Yhim, Ho-Young; Lee, Myung-won; Lee, Je-Jung; Jung, Sung-Hoon; Bang, Soo-Mee; Kim, Kihyun

Daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible Asian patients with newly diagnosed multiple myeloma: final analysis of the phase 3 OCTANS study (Sept, 10.1007/s00277-024-05958-8, 2024)

ANNALS OF HEMATOLOGY

IF2.4

2024-09-23

OAAI

Fu, Weijun; Bang, Soo-Mee; Huang, Honghui; Kim, Kihyun; Li, Wei; An, Gang; Lee, Je-Jung; Cai, Zhen; Jin, Jie; Wang, Yafei; Chim, Chor Sang; Carson, Robin; Liu, Rui; Zhao, Man; Chen, Xi; Cui, Canchan; Hou, Jian; Wang, Jianxiang

ANNALS OF HEMATOLOGY

IF2.4

2024-09-04

OAAI

Superior outcomes and high-risk features with carfilzomib, lenalidomide, and dexamethasone combination therapy for patients with relapsed and refractory multiple myeloma: results of the multicenter KMMWP2201 study

HAEMATOLOGICA

IF7.9

2024-06-06

OAAI

Lee, Ji Hyun; Choi, Jimin; Min, Chang-Ki; Park, Sung-Soo; Jo, Jae-Cheol; Lee, Yoo Jin; Kim, Jin Seok; Eom, Hyeon-Seok; Jung, Jongheon; Moon, Joon Ho; Cho, Hee Jeong; Lee, Myung-won; Yoon, Sung-Soo; Byun, Ja Min; Lee, Jae Hoon; Lee, Je-Jung; Jung, Sung-Hoon; Shin, Ho-Jin; Kim, Do Young; Yi, Jun Ho; Lee, Seung-Shin; Do, Young Rok; Yoon, Dok Hyun; Cho, Hyungwoo; Lee, Won Sik; Lee, Ho Sup; Uhm, Jieun; Kim, Hyo Jung; Jang, Hee Ryeong; Kim, Sung-Hyun; Kim, Kihyun

Validation of the 2022 European LeukemiaNet risk stratification for acute myeloid leukemia 2022欧洲白血病风险分层对急性髓系白血病的验证

SCIENTIFIC REPORTS

IF3.9

2024-04-12

OAAI

Song, Ga-Young; Kim, Hyeon-Jong; Kim, Taehyung; Ahn, Seo-Yeon; Jung, Sung-Hoon; Kim, Mihee; Yang, Deok-Hwan; Lee, Je-Jung; Kim, Mi Yeon; Cheong, June-Won; Jung, Chul Won; Jang, Jun Ho; Kim, Hee- Je; Moon, Joon Ho; Sohn, Sang Kyun; Won, Jong-Ho; Park, Seong Kyu; Kim, Sung-Hyun; Choi, Chang Kyun; Kim, Hyeoung-Joon; Ahn, Jae-Sook; Kim, Dennis Dong Hwan

Development of an anti-PD-L1 CAR T therapeutic treating advanced gastric cancer with enhanced efficacy and lower off-tumor activities

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Baek, Minwoo; Yu, Jae-In; Choi, Eun-Ji; Lim, Yeojin; Yang, Jiwon; Choi, Se-Ryeong; Choi, Yoonjoo; Kim, Mihwa; Rhee, Joon Haeng; Lee, Je-Jung

Efficacy of natural killer cell therapy combined with chemoradiotherapy in murine models of head and neck squamous cell carcinoma

CYTOTHERAPY

IF3.2

2024-03-01

PREAI

Jung, Eun Kyung; Chu, Tan -Huy; Kim, Sun-Ae; Vo, Manh-Cuong; Nguyen, Van -Tan; Lee, Kyung-Hwa; Jung, Sung-Hoon; Yoon, Meesun; Cho, Duck; Lee, Je -Jung; Yoon, Tae Mi

Evaluation of the R2-ISS in real-world patients with newly diagnosed multiple myeloma: A nationwide cohort study by the Korean Multiple Myeloma Working Party (KMM 2202)

HEMASPHERE

IF14.6

2024-01-26

OAAI

Cho, Hyungwoo; Kim, Kihyun; Yoon, Sang Eun; Jung, Sung-Hoon; Lee, Je-Jung; Moon, Joon Ho; Cho, Hee Jeong; Lee, Ho Sup; Kang, Ka-Won; Kim, Sung-Yong; Eom, Hyeon-Seok; Mun, Yeung-Chul; Park, Young Hoon; Yoon, Sung-Soo; Do, Young Rok; Lee, Won Sik; Min, Chang-Ki; Yoon, Dok Hyun

Real-world outcome of patients with extensively pretreated multiple myeloma who were treated with selinexor and dexamethasone: a Korean multicenter retrospective analysis 接受selinexor和地塞米松治疗的广泛预处理的多发性骨髓瘤患者的真实世界结果: 韩国多中心回顾性分析

ANNALS OF HEMATOLOGY

IF2.4

2024-01-25

PREAI

Yi, Jun Ho; Park, Sung-Soo; Min, Chang-Ki; Eom, Hyeon-Seok; Byun, Ja Min; Koh, Youngil; Yoon, Sung-Soo; Lee, Jae Hoon; Jung, Sung-Hoon; Lee, Je-Jung; Yoon, Sang Eun; Woo, Sook-young; Kim, Kihyun

Carfilzomib, thalidomide, and dexamethasone are safe and effective in relapsed and/or refractory multiple myeloma: final report of the single-arm, multicenter, phase II ALLG MM018/AMN002 study

HAEMATOLOGICA

IF7.9

2024-01-18

OAAI

Ninkovic, Slavisa; Harrison, Simon J.; Lee, Je-Jung; Murphy, Nick; Lee, Jae Hoon; Estell, Jane; Chen, Vivien M.; Horvath, Noemi; Kim, Kihuyn; Eek, Richard; Augustson, Bradley; Bang, Soo -Mee; Huang, Shang-Yi; Rajagopal, Rajeev; Szabo, Ferenc; Engeler, Daniel; Butcher, Belinda E.; Mollee, Peter; Durie, Brian; Chng, Wee Joo; Quach, Hang

Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment

FRONTIERS IN ONCOLOGY

IF3.3

2023-11-03

OAAI

Vu, Son Hai; Pham, Ha Hong; Pham, Thao Thi Phuong; Le, Thanh Thien; Vo, Manh-Cuong; Jung, Sung-Hoon; Lee, Je-Jung; Nguyen, Xuan-Hung

Open-labeled, multicenter phase II study of prophylactic administration of pegylated granulocyte colony-stimulating factor in relapsed or refractory multiple myeloma who received pomalidomide-based regimens (KMM170)

FRONTIERS IN ONCOLOGY

IF3.3

2023-10-25

OAAI

Song, Ga-Young; Lee, Je-Jung; Moon, Joon Ho; Kim, Dajung; Kim, Min Kyoung; Kim, Hyo Jung; Mun, Yeung-Chul; Lee, Won-Sik; Do, Young Rok; Lee, Jae Hoon; Jung, Sung-Hoon; Kim, Jin Seok

Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)白消安加美法仑与大剂量美法仑作为具有高风险特征的多发性骨髓瘤自体干细胞移植的预处理方案 (KMM 2015)

ANNALS OF HEMATOLOGY

IF2.4

2023-07-01

PREAI

Kim, Mihee; Lee, Je-Jung; Min, Chang-Ki; Lee, Ji Yun; Jo, Jae-Cheol; Yoon, Sung-Soo; Lim, Sung-Nam; Do, Young Rok; Kim, Kihyun; Lee, Jae Hoon; Yoo, Kwai Han; Bae, Sung Hwa; Yi, Jun Ho; Jung, Jongheon; Eom, Hyeon-Seok; Jung, Sung-Hoon

研究方向